Deborah E Citrin

16PUBLICATIONS

129CO-AUTHORS

Molecular targetsRadiation therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Natural language processing

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (16)

Sort by Publication Date:

|May 25, 2026

Ablation of glypican-3 enhances radiosensitivity in liver cancer by prolonging G2/M arrest and activating the ATM/CHK2 pathway.

|Mar 04, 2026

Effects of Radiotherapy in Normal Tissue.

Deborah E Citrin, Robert D Timmerman

|Oct 23, 2025

National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.

David J Einstein, Melissa L Abel, Jeanny B Aragon-Ching

|Oct 02, 2025

Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence.

Anson T Ku, Uma Shankavaram, Shana Y Trostel

|Aug 18, 2025

p53-miR-34a feedback in lung fibroblasts regulates antifibrotic effects of CSP7, nintedanib, and pirfenidone.

Liang Fan, Rashmi S Shetty, Huy Minh Dao

|Sep 03, 2024

Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926.

Douglas M Dahl, Joseph P Rodgers, William U Shipley

Pageof 3

Frequent Collaborators

Howard M Sandler

Krishnan R Patel

Peter L Choyke

Jeff M Michalski

Baris Turkbey

Fabio L Cury

Daniel J Krauss

Gerard Morton

Deborah Watkins Bruner

2 joint publications

Jason Alexander Efstathiou

Frequent Collaborators

Howard M Sandler

Krishnan R Patel

Peter L Choyke

Jeff M Michalski